{"id":"W3182001862","doi":"10.1016/j.nbt.2021.07.001","title":"Opinion: Independent third-party entities as a model for validation of commercial antibodies","year":2021,"lang":"en","type":"article","venue":"New Biotechnology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Montreal Neurological Institute and Hospital; University of Toronto; McGill University; Structural Genomics Consortium","funders":"Ontario Genomics Institute; National Institute of General Medical Sciences; National Institute on Aging; Kungliga Tekniska Högskolan; Genentech; Innovative Medicines Initiative; Canada Foundation for Innovation; European Federation of Pharmaceutical Industries and Associations; ALS Association; Wellcome Trust; Janssen Pharmaceuticals; Merck KGaA; National Institutes of Health; Ontario Genomics; Genome Canada; Bayer; ALS Society of Canada; Takeda Canada; Royal Society of Canada; McGill University; Boehringer Ingelheim; Pfizer; Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Foundation for the National Institutes of Health","keywords":"Incentive; Public domain; Computer science; Profit (economics); Domain (mathematical analysis); Antibody; Public opinion; Business; Data science; Political science; Economics; Medicine; Immunology; Microeconomics; Mathematics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06111459,0.0007211321,0.001154853,0.0009174232,0.003728536,0.008844884,0.008294348,0.04516609,0.008348831],"category_scores_gemma":[0.1178351,0.0006738302,0.002584877,0.0009387129,0.01219655,0.01311031,0.00462517,0.03592917,0.00551349],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007757636,"about_ca_system_score_gemma":0.01979811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008540854,"about_ca_topic_score_gemma":0.007258155,"domain_scores_codex":[0.9484056,0.01047588,0.003775336,0.006152913,0.02696305,0.004227124],"domain_scores_gemma":[0.8164031,0.09998596,0.007686208,0.009640857,0.05919556,0.007088339],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001732144,0.00009945699,0.001444926,0.0004993889,0.0001305263,0.0008333924,0.0009900767,0.0004237002,0.001593377,0.2783785,0.6856061,0.02982735],"study_design_scores_gemma":[0.000115947,0.000111343,0.001290875,0.001186944,0.0002059251,0.0009803799,0.001033016,0.002501676,0.001856372,0.1283527,0.8622209,0.0001440133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.002480649,0.001889288,0.01296968,0.9519563,0.01503446,0.0001028476,0.0002436898,0.0001140164,0.01520896],"genre_scores_gemma":[0.05720516,0.001769359,0.0159078,0.8967016,0.01230313,0.0002946933,0.0003103698,0.00008213659,0.01542581],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.9388854,"threshold_uncertainty_score":0.3232087,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06077089442729143,"score_gpt":0.3609028639170184,"score_spread":0.300131969489727,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}